143 related articles for article (PubMed ID: 26765486)
1. Multivalency in the recognition and antagonism of a HIV TAR RNA-TAT assembly using an aminoglycoside benzimidazole scaffold.
Kumar S; Ranjan N; Kellish P; Gong C; Watkins D; Arya DP
Org Biomol Chem; 2016 Feb; 14(6):2052-6. PubMed ID: 26765486
[TBL] [Abstract][Full Text] [Related]
2. Recognition of HIV TAR RNA by triazole linked neomycin dimers.
Kumar S; Arya DP
Bioorg Med Chem Lett; 2011 Aug; 21(16):4788-92. PubMed ID: 21757341
[TBL] [Abstract][Full Text] [Related]
3. Recognition of HIV-TAR RNA using neomycin-benzimidazole conjugates.
Ranjan N; Kumar S; Watkins D; Wang D; Appella DH; Arya DP
Bioorg Med Chem Lett; 2013 Oct; 23(20):5689-93. PubMed ID: 24012122
[TBL] [Abstract][Full Text] [Related]
4. Binding of neomycin to the TAR element of HIV-1 RNA induces dissociation of Tat protein by an allosteric mechanism.
Wang S; Huber PW; Cui M; Czarnik AW; Mei HY
Biochemistry; 1998 Apr; 37(16):5549-57. PubMed ID: 9548939
[TBL] [Abstract][Full Text] [Related]
5. Click dimers to target HIV TAR RNA conformation.
Kumar S; Kellish P; Robinson WE; Wang D; Appella DH; Arya DP
Biochemistry; 2012 Mar; 51(11):2331-47. PubMed ID: 22339203
[TBL] [Abstract][Full Text] [Related]
6. Conformational constraint as a means for understanding RNA-aminoglycoside specificity.
Blount KF; Zhao F; Hermann T; Tor Y
J Am Chem Soc; 2005 Jul; 127(27):9818-29. PubMed ID: 15998086
[TBL] [Abstract][Full Text] [Related]
7. Neamine dimers targeting the HIV-1 TAR RNA.
Riguet E; Désiré J; Boden O; Ludwig V; Göbel M; Bailly C; Décout JL
Bioorg Med Chem Lett; 2005 Nov; 15(21):4651-5. PubMed ID: 16153833
[TBL] [Abstract][Full Text] [Related]
8. TAR-RNA recognition by a novel cyclic aminoglycoside analogue.
Raghunathan D; Sánchez-Pedregal VM; Junker J; Schwiegk C; Kalesse M; Kirschning A; Carlomagno T
Nucleic Acids Res; 2006; 34(12):3599-608. PubMed ID: 16855296
[TBL] [Abstract][Full Text] [Related]
9. Development of Small Molecules with a Noncanonical Binding Mode to HIV-1 Trans Activation Response (TAR) RNA.
Abulwerdi FA; Shortridge MD; Sztuba-Solinska J; Wilson R; Le Grice SF; Varani G; Schneekloth JS
J Med Chem; 2016 Dec; 59(24):11148-11160. PubMed ID: 28002966
[TBL] [Abstract][Full Text] [Related]
10. Understanding the characteristics of nonspecific binding of drug-like compounds to canonical stem-loop RNAs and their implications for functional cellular assays.
Kelly ML; Chu CC; Shi H; Ganser LR; Bogerd HP; Huynh K; Hou Y; Cullen BR; Al-Hashimi HM
RNA; 2021 Jan; 27(1):12-26. PubMed ID: 33028652
[TBL] [Abstract][Full Text] [Related]
11. Inhibitors of protein-RNA complexation that target the RNA: specific recognition of human immunodeficiency virus type 1 TAR RNA by small organic molecules.
Mei HY; Cui M; Heldsinger A; Lemrow SM; Loo JA; Sannes-Lowery KA; Sharmeen L; Czarnik AW
Biochemistry; 1998 Oct; 37(40):14204-12. PubMed ID: 9760258
[TBL] [Abstract][Full Text] [Related]
12. Alpha,alpha-trehalose derivatives bearing guanidino groups as inhibitors to HIV-1 Tat-TAR RNA interaction in human cells.
Wang M; Xu Z; Tu P; Yu X; Xiao S; Yang M
Bioorg Med Chem Lett; 2004 May; 14(10):2585-8. PubMed ID: 15109657
[TBL] [Abstract][Full Text] [Related]
13. Effect of salt concentration on the conformation of TAR RNA and its association with aminoglycoside antibiotics.
Smith AL; Kassman J; Srour KJ; Soto AM
Biochemistry; 2011 Nov; 50(44):9434-45. PubMed ID: 21916409
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of aminoglycoside-3'-conjugates of 2'-O-methyl oligoribonucleotides and their invasion to a 19F labeled HIV-1 TAR model.
Kiviniemi A; Virta P
Bioconjug Chem; 2011 Aug; 22(8):1559-66. PubMed ID: 21688836
[TBL] [Abstract][Full Text] [Related]
15. Synthetic access to spacer-linked 3,6-diamino-2,3,6-trideoxy-alpha-D-glucopyranosides--potential aminoglycoside mimics for the inhibition of the HIV-1 TAR-RNA/Tat-peptide complex.
Jöge T; Jesberger M; Bröker P; Kirschning A
Carbohydr Res; 2007 Sep; 342(12-13):1704-14. PubMed ID: 17562328
[TBL] [Abstract][Full Text] [Related]
16. Targeting the HIV trans-activation responsive region--approaches towards RNA-binding drugs.
Krebs A; Ludwig V; Boden O; Göbel MW
Chembiochem; 2003 Oct; 4(10):972-8. PubMed ID: 14523913
[No Abstract] [Full Text] [Related]
17. A peptide nucleic acid-neamine conjugate that targets and cleaves HIV-1 TAR RNA inhibits viral replication.
Riguet E; Tripathi S; Chaubey B; Désiré J; Pandey VN; Décout JL
J Med Chem; 2004 Sep; 47(20):4806-9. PubMed ID: 15369382
[TBL] [Abstract][Full Text] [Related]
18. RNA as a target for drug design, the example of Tat-TAR interaction.
Froeyen M; Herdewijn P
Curr Top Med Chem; 2002 Oct; 2(10):1123-45. PubMed ID: 12173971
[TBL] [Abstract][Full Text] [Related]
19. Ligand-induced changes in 2-aminopurine fluorescence as a probe for small molecule binding to HIV-1 TAR RNA.
Bradrick TD; Marino JP
RNA; 2004 Sep; 10(9):1459-68. PubMed ID: 15273324
[TBL] [Abstract][Full Text] [Related]
20. Docking of cationic antibiotics to negatively charged pockets in RNA folds.
Hermann T; Westhof E
J Med Chem; 1999 Apr; 42(7):1250-61. PubMed ID: 10197968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
